Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Cigna Group (NYSE: CI) was $269.96 for the day, down -0.29% from the previous closing price of $270.74. In other words, the price has decreased by -$0.29 from its previous closing price. On the day, 2.15 million shares were traded. CI stock price reached its highest trading level at $274.6 during the session, while it also had its lowest trading level at $266.29.
Ratios:
Our analysis of CI’s different ratios will help us gain a deeper understanding of the company. In the meantime, Its Debt-to-Equity ratio is 0.77 whereas as Long-Term Debt/Eq ratio is at 0.66.
On June 26, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $400.
On May 30, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $388.Robert W. Baird initiated its Outperform rating on May 30, 2024, with a $388 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 09 ’25 when Palmer Eric P bought 610 shares for $335.08 per share.
Palmer Eric P bought 14,985 shares of CI for $5,029,097 on May 08 ’25. On May 07 ’25, another insider, Palmer Eric P, who serves as the Former Officer of the company, bought 87,171 shares for $335.03 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CI now has a Market Capitalization of 72059879424 and an Enterprise Value of 97901903872. As of this moment, Cigna’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.74, and their Forward P/E ratio for the next fiscal year is 8.18. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.36. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.28 while its Price-to-Book (P/B) ratio in mrq is 1.79. Its current Enterprise Value per Revenue stands at 0.374 whereas that against EBITDA is 8.582.
Stock Price History:
The Beta on a monthly basis for CI is 0.48, which has changed by -0.19419736 over the last 52 weeks, in comparison to a change of 0.19283521 over the same period for the S&P500. Over the past 52 weeks, CI has reached a high of $370.83, while it has fallen to a 52-week low of $256.89. The 50-Day Moving Average of the stock is -11.84%, while the 200-Day Moving Average is calculated to be -12.97%.
Shares Statistics:
CI traded an average of 1.92M shares per day over the past three months and 2531340 shares per day over the past ten days. A total of 266.60M shares are outstanding, with a floating share count of 262.90M. Insiders hold about 1.51% of the company’s shares, while institutions hold 91.74% stake in the company. Shares short for CI as of 1752537600 were 2882831 with a Short Ratio of 1.50, compared to 1749772800 on 2953657. Therefore, it implies a Short% of Shares Outstanding of 2882831 and a Short% of Float of 1.43.
Dividends & Splits
With its trailing 12-month dividend rate of 5.82, CI has a forward annual dividend rate of 5.82. Against a Trailing Annual Dividend Yield of 0.02149664The stock’s 5-year Average Dividend Yield is 1.34. The current Payout Ratio is 46.19% for CI, which recently paid a dividend on 2025-06-03 with an ex-dividend date of 2025-09-04. Stock splits for the company last occurred on 2007-06-05 when the company split stock in a 3:1 ratio.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 22.0 analysts currently analyzing and rating the stock of Cigna Group (CI).The consensus estimate for the next quarter is $8.03, with high estimates of $8.47 and low estimates of $7.48.
Analysts are recommending an EPS of between $29.86 and $29.23 for the fiscal current year, implying an average EPS of $29.66. EPS for the following year is $33.04, with 24.0 analysts recommending between $34.15 and $32.07.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 9 analysts. It ranges from a high estimate of $68.59B to a low estimate of $64.85B. As of the current estimate, Cigna Group’s year-ago sales were $63.69BFor the next quarter, 9 analysts are estimating revenue of $68.32B. There is a high estimate of $70.44B for the next quarter, whereas the lowest estimate is $65.6B.
A total of 17 analysts have provided revenue estimates for CI’s current fiscal year. The highest revenue estimate was $271.25B, while the lowest revenue estimate was $253.07B, resulting in an average revenue estimate of $262.65B. In the same quarter a year ago, actual revenue was $247.1BBased on 17 analysts’ estimates, the company’s revenue will be $272.74B in the next fiscal year. The high estimate is $289.14B and the low estimate is $261.94B.
